Glutamate-mediated transmission, alcohol, and alcoholism
- PMID: 10871702
- DOI: 10.1016/s0197-0186(00)00061-9
Glutamate-mediated transmission, alcohol, and alcoholism
Abstract
Glutamate-mediated neurotransmission may be involved in the range of adaptive changes in brain which occur after ethanol administration in laboratory animals, and in chronic alcoholism in human cases. Excitatory amino acid transmission is modulated by a complex system of receptors and other effectors, the efficacy of which can be profoundly affected by altered gene or protein expression. Local variations in receptor composition may underlie intrinsic regional variations in susceptibility to pathological change. Equally, ethanol use and abuse may bring about alterations in receptor subunit expression as the essence of the adaptive response. Such considerations may underlie the regional localization characteristic of the pathogenesis of alcoholic brain damage, or they may form part of the homeostatic change that constitutes the neural substrate for alcohol dependence.
Similar articles
-
The role of glutamatergic neurotransmission in the pathophysiology of alcoholism.Annu Rev Med. 1998;49:173-84. doi: 10.1146/annurev.med.49.1.173. Annu Rev Med. 1998. PMID: 9509257 Review.
-
[Excitatory neurotransmission in alcoholism].Fortschr Neurol Psychiatr. 2003 Jul;71 Suppl 1:S36-44. doi: 10.1055/s-2003-40504. Fortschr Neurol Psychiatr. 2003. PMID: 12947542 Review. German.
-
The glutamatergic basis of human alcoholism.Am J Psychiatry. 1995 Mar;152(3):332-40. doi: 10.1176/ajp.152.3.332. Am J Psychiatry. 1995. PMID: 7864257 Review.
-
Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal.Am J Psychiatry. 1998 Jun;155(6):726-32. doi: 10.1176/ajp.155.6.726. Am J Psychiatry. 1998. PMID: 9619143
-
Glutamatergic transmission in opiate and alcohol dependence.Ann N Y Acad Sci. 2003 Nov;1003:196-211. doi: 10.1196/annals.1300.012. Ann N Y Acad Sci. 2003. PMID: 14684447 Review.
Cited by
-
The efficacy of a low dose combination of topiramate and naltrexone on ethanol reinforcement and consumption in rat models.Pharmacol Biochem Behav. 2014 Jan;116:107-15. doi: 10.1016/j.pbb.2013.11.013. Epub 2013 Nov 16. Pharmacol Biochem Behav. 2014. PMID: 24252444 Free PMC article.
-
The expression of NMDA receptor subunit mRNA in human chronic alcoholics.Ann N Y Acad Sci. 2008 Oct;1139:10-9. doi: 10.1196/annals.1432.053. Ann N Y Acad Sci. 2008. PMID: 18991843 Free PMC article.
-
Catatonia as a presenting feature of alcohol withdrawal: a case report.Prim Care Companion J Clin Psychiatry. 2007;9(6):465. doi: 10.4088/pcc.v09n0611a. Prim Care Companion J Clin Psychiatry. 2007. PMID: 18185829 Free PMC article. No abstract available.
-
A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers.Exp Clin Psychopharmacol. 2009 Apr;17(2):122-9. doi: 10.1037/a0015700. Exp Clin Psychopharmacol. 2009. PMID: 19331489 Free PMC article. Clinical Trial.
-
Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.Addict Biol. 2017 May;22(3):581-615. doi: 10.1111/adb.12349. Epub 2016 Feb 1. Addict Biol. 2017. PMID: 26833803 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical